Dunne, P D, Coleman, H G, Bankhead, P, Alderdice, M, Gray, R T, McQuaid, S, Bingham, V, Loughrey, M B, James, J A, McCorry, A M B, Gilmore, A, Holohan, C, Klingbiel, D, Tejpar, S, Johnston, P G, McArt, D G, Di Nicolantonio, F, Longley, D B & Lawler, M 2018, ' Bcl-xL as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in-mutant stage II and III colon cancer ', Oncotarget, vol. 9, no. 17, pp. 0 . https://doi.org/10.18632/oncotarget.24481